Source: European Medicines Agency (EU) Revision Year: 2022 Publisher: Amryt Pharmaceuticals DAC, 45 Mespil Road, Dublin 4, Ireland tel: 00 800 4447 4447 (toll free) tel: +44 1604 549 952 e-mail: medinfo@amrytpharma.com
Filsuvez gel.
Pharmaceutical Form |
---|
Gel. Colourless to slightly yellowish, opalescent, non-aqueous gel. |
1 g of gel contains 100 mg of extract (as dry extract, refined) from Betula pendula Roth, Betula pubescens Ehrh. as well as hybrids of both species, cortex (equivalent to 0.5-1.0 g birch bark), including 84-95 mg triterpenes calculated as the sum of betulin, betulinic acid, erythrodiol, lupeol and oleanolic acid.
Extraction solvent: n-Heptane.
For the full list of excipients, see section 6.1.
Active Ingredient | Description | |
---|---|---|
Betulin |
Betulin accelerated re-epithelialization in an in vitro wound scratch assay using human primary keratinocytes at the dosage of 1 ฮผg/ml, and in a porcine ex vivo wound healing model at the dosage of 10 ยตg/ml. The precise mechanism of action of the active substance in wound healing in humans is not known. |
List of Excipients |
---|
Sunflower oil, refined |
White collapsible aluminium tube, interior lacquered with epoxy phenolic coating, and with a sealing compound in the fold. The tube is closed with a tamper-evident aluminium membrane and fitted with a white polypropylene screw cap. The tube is packed in a carton.
Pack sizes: 1 tube of 9.4 g or 23.4 g gel.
Not all pack sizes may be marketed.
Amryt Pharmaceuticals DAC, 45 Mespil Road, Dublin 4, Ireland
tel: 00 800 4447 4447 (toll free)
tel: +44 1604 549 952
e-mail: medinfo@amrytpharma.com
EU/1/22/1652/001 9.4 g tube
EU/1/22/1652/002 23.4 g tube
Drug | Countries | |
---|---|---|
FILSUVEZ | Austria, Estonia, France, Croatia, Ireland, Italy, Lithuania, Romania, United Kingdom |
ยฉ All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.